{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:09:21Z","timestamp":1793236161027,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","award":["2017YFC0907600"],"award-info":[{"award-number":["2017YFC0907600"]}],"id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10067-023-06660-2","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T13:01:56Z","timestamp":1687179716000},"page":"2823-2832","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Retrospective comparative study of the efficacy of JAK inhibitor (tofacitinib) in the treatment of systemic sclerosis-associated interstitial lung disease"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8445-7769","authenticated-orcid":false,"given":"Zhou","family":"Junfei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao","family":"Meihua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Xiangting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Tianming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yajing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Lipu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"issue":"4","key":"6660_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","volume":"37","author":"H Chifflot","year":"2008","unstructured":"Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J (2008) Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 37(4):223\u2013235. https:\/\/doi.org\/10.1016\/j.semarthrit.2007.05.003","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"6660_CR2","first-page":"40","volume":"106","author":"M Rubio-Rivas","year":"2017","unstructured":"Rubio-Rivas M, Simeon-Aznar CP, Velasco C, Mari-Alfonso B, Espinosa G, Corbella X et al (2017) Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE). Clin Exp Rheumatol 106(4):40\u20137","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"6660_CR3","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972\u20132002. Ann Rheum Dis 66(7):940\u2013944. https:\/\/doi.org\/10.1136\/ard.2006.066068","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6660_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13075-021-02536-5","volume":"23","author":"C Campochiaro","year":"2021","unstructured":"Campochiaro C, Allanore Y (2021) An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years. Arthritis Res Ther 23(1):155. https:\/\/doi.org\/10.1186\/s13075-021-02536-5","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"6660_CR5","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/BOR.0000000000000795","volume":"33","author":"D Roofeh","year":"2021","unstructured":"Roofeh D, Lescoat A, Khanna D (2021) Treatment for systemic sclerosis-associated interstitial lung disease. Curr Opin Rheumatol 33(3):240\u2013248. https:\/\/doi.org\/10.1097\/BOR.0000000000000795","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"6660_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40259-019-00333-w","volume":"33","author":"A Tv","year":"2019","unstructured":"Tv A, Haikarainen T, Raivola J, Silvennoinen O (2019) Selective JAKinibs: prospects in inflammatory and autoimmune diseases. BioDrugs 33(1):15\u201332. https:\/\/doi.org\/10.1007\/s40259-019-00333-w","journal-title":"BioDrugs"},{"issue":"3","key":"6660_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12016-020-08786-6","volume":"59","author":"H You","year":"2020","unstructured":"You H, Xu D, Zhao J, Li J, Wang Q, Tian X et al (2020) JAK inhibitors: prospects in connective tissue diseases. Clin Rev Allergy Immunol 59(3):334\u2013351. https:\/\/doi.org\/10.1007\/s12016-020-08786-6","journal-title":"Clin Rev Allergy Immunol"},{"key":"6660_CR8","doi-asserted-by":"publisher","first-page":"114103","DOI":"10.1016\/j.bcp.2020.114103","volume":"178","author":"A Lescoat","year":"2020","unstructured":"Lescoat A, Lelong M, Jeljeli M, Piquet-Pellorce C, Morzadec C, Ballerie A et al (2020) Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: perspectives for scleroderma-associated interstitial lung disease. Biochem Pharmacol 178:114103. https:\/\/doi.org\/10.1016\/j.bcp.2020.114103","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"6660_CR9","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum 65(11):2737\u20132747. https:\/\/doi.org\/10.1002\/art.38098","journal-title":"Arthritis Rheum"},{"key":"6660_CR10","doi-asserted-by":"publisher","unstructured":"Chung JH, Walker CM, Hobbs S (2020) Imaging features of systemic sclerosis-associated interstitial lung disease. J Vis Exp (160). https:\/\/doi.org\/10.3791\/60300","DOI":"10.3791\/60300"},{"issue":"3","key":"6660_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1148\/radiol.2462070712","volume":"246","author":"DM Hansell","year":"2008","unstructured":"Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246(3):697\u2013722. https:\/\/doi.org\/10.1148\/radiol.2462070712","journal-title":"Radiology"},{"issue":"4","key":"6660_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/annrheumdis-2017-211912","volume":"77","author":"AL Herrick","year":"2018","unstructured":"Herrick AL, Peytrignet S, Lunt M, Pan X, Hesselstrand R, Mouthon L et al (2018) Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. Ann Rheum Dis 77(4):563\u2013570. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211912","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6660_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13075-019-1919-6","volume":"21","author":"KM Matsuda","year":"2019","unstructured":"Matsuda KM, Yoshizaki A, Kuzumi A, Fukasawa T, Ebata S, Miura S et al (2019) Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study. Arthritis Res Ther 21(1):129. https:\/\/doi.org\/10.1186\/s13075-019-1919-6","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"6660_CR14","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1007\/s10067-018-4289-6","volume":"37","author":"X Dong","year":"2018","unstructured":"Dong X, Zhou J, Guo X, Li Y, Xu Y, Fu Q et al (2018) A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjogren\u2019s syndrome-related interstitial lung disease in a Chinese population. Clin Rheumatol 37(11):2981\u20132988. https:\/\/doi.org\/10.1007\/s10067-018-4289-6","journal-title":"Clin Rheumatol"},{"issue":"10","key":"6660_CR15","first-page":"1520","volume":"18","author":"JH Warrick","year":"1991","unstructured":"Warrick JH, Bhalla M, Schabel SI, Silver RM (1991) High resolution computed tomography in early scleroderma lung disease. J Rheumatol 18(10):1520\u20131528","journal-title":"J Rheumatol"},{"issue":"2","key":"6660_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/annrheumdis-2020-217230","volume":"80","author":"P Spagnolo","year":"2021","unstructured":"Spagnolo P, Distler O, Ryerson CJ, Tzouvelekis A, Lee JS, Bonella F et al (2021) Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs). Ann Rheum Dis 80(2):143\u2013150. https:\/\/doi.org\/10.1136\/annrheumdis-2020-217230","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"6660_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1177\/2397198319865367","volume":"5","author":"W Wang","year":"2020","unstructured":"Wang W, Bhattacharyya S, Marangoni RG, Carns M, Dennis-Aren K, Yeldandi A et al (2020) The JAK\/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib. J Scleroderma Relat Disord 5(1):40\u201350. https:\/\/doi.org\/10.1177\/2397198319865367","journal-title":"J Scleroderma Relat Disord"},{"key":"6660_CR18","doi-asserted-by":"publisher","unstructured":"Fiorentini E, Bonomi F, Peretti S, Orlandi M, Lepri G, Matucci Cerinic M, et al. (2022) Potential role of JAK inhibitors in the treatment of systemic sclerosis-associated interstitial lung disease: a narrative review from pathogenesis to real-life data. Life (Basel) 12(12). https:\/\/doi.org\/10.3390\/life12122101","DOI":"10.3390\/life12122101"},{"key":"6660_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2021.1907014","author":"Y Yoshida","year":"2021","unstructured":"Yoshida Y, Sugimoto T, Hosokawa Y, Suma H, Kobayashi H, Ishitoku M et al (2021) C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids. Mod Rheumatol. https:\/\/doi.org\/10.1080\/14397595.2021.1907014","journal-title":"Mod Rheumatol"},{"issue":"3","key":"6660_CR20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.5606\/ArchRheumatol.2018.6630","volume":"33","author":"E Jung","year":"2018","unstructured":"Jung E, Suh CH, Kim HA, Jung JY (2018) Clinical characteristics of systemic sclerosis with interstitial lung disease. Arch Rheumatol 33(3):322\u2013327. https:\/\/doi.org\/10.5606\/ArchRheumatol.2018.6630","journal-title":"Arch Rheumatol"},{"issue":"10","key":"6660_CR21","first-page":"1254","volume":"29","author":"K Kusume","year":"1991","unstructured":"Kusume K (1991) Lung injury in idiopathic pulmonary fibrosis and measurement of immunoreactive neutrophil elastase and alpha 1-protease inhibitor in blood. Nihon Kyobu Shikkan Gakkai Zasshi 29(10):1254\u20131260","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"issue":"2 Suppl","key":"6660_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/2397198320903867","volume":"5","author":"SI Nihtyanova","year":"2020","unstructured":"Nihtyanova SI, Denton CP (2020) Pathogenesis of systemic sclerosis associated interstitial lung disease. J Scleroderma Relat Disord 5(2 Suppl):6\u201316. https:\/\/doi.org\/10.1177\/2397198320903867","journal-title":"J Scleroderma Relat Disord"},{"issue":"5","key":"6660_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","volume":"77","author":"S Banerjee","year":"2017","unstructured":"Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM (2017) JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs 77(5):521\u2013546. https:\/\/doi.org\/10.1007\/s40265-017-0701-9","journal-title":"Drugs"},{"issue":"10","key":"6660_CR24","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s00296-021-04956-7","volume":"41","author":"RV Karalilova","year":"2021","unstructured":"Karalilova RV, Batalov ZA, Sapundzhieva TL, Matucci-Cerinic M, Batalov AZ (2021) Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound. Rheumatol Int 41(10):1743\u20131753. https:\/\/doi.org\/10.1007\/s00296-021-04956-7","journal-title":"Rheumatol Int"},{"issue":"8","key":"6660_CR25","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1111\/jdv.14876","volume":"32","author":"SC Deverapalli","year":"2018","unstructured":"Deverapalli SC, Rosmarin D (2018) The use of JAK inhibitors in the treatment of progressive systemic sclerosis. J Eur Acad Dermatol Venereol 32(8):e328. https:\/\/doi.org\/10.1111\/jdv.14876","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"6660_CR26","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1093\/rheumatology\/keaa613","volume":"60","author":"H You","year":"2021","unstructured":"You H, Xu D, Hou Y, Zhou J, Wang Q, Li M et al (2021) Tofacitinib as a possible treatment for skin thickening in diffuse cutaneous systemic sclerosis. Rheumatology (Oxford) 60(5):2472\u20132477. https:\/\/doi.org\/10.1093\/rheumatology\/keaa613","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"6660_CR27","first-page":"1","volume":"28","author":"F Be","year":"1949","unstructured":"Be F, Cournand A, Richards DW Jr (1949) Pulmonary insufficiency; a study of 39 cases of pulmonary fibrosis. Medicine (Baltimore) 28(1):1\u201325","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"6660_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/rheumatology\/keg033","volume":"42","author":"CP Simeon","year":"2003","unstructured":"Simeon CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M et al (2003) Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology (Oxford) 42(1):71\u201375. https:\/\/doi.org\/10.1093\/rheumatology\/keg033","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"6660_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/ard.62.2.146","volume":"62","author":"C Morgan","year":"2003","unstructured":"Morgan C, Knight C, Lunt M, Black CM, Silman AJ (2003) Predictors of end stage lung disease in a cohort of patients with scleroderma. Ann Rheum Dis 62(2):146\u2013150. https:\/\/doi.org\/10.1136\/ard.62.2.146","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 91","key":"6660_CR30","first-page":"S111","volume":"33","author":"OA Moore","year":"2015","unstructured":"Moore OA, Proudman SM, Goh N, Corte TJ, Rouse H, Hennessy O et al (2015) Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease. Clin Exp Rheumatol 33(4 Suppl 91):S111\u2013S116 (PMID: 26243401)","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"6660_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00292-020-00902-9","volume":"42","author":"A Fisseler-Eckhoff","year":"2021","unstructured":"Fisseler-Eckhoff A, Marker-Hermann E (2021) Interstitial lung disease associated with connective tissue disease. Pathologe 42(1):4\u201310. https:\/\/doi.org\/10.1007\/s00292-020-00902-9","journal-title":"Pathologe"},{"key":"6660_CR32","doi-asserted-by":"publisher","DOI":"10.1067\/j.cpradiol.2021.07.007","author":"L Cereser","year":"2021","unstructured":"Cereser L, Passarotti E, De Pellegrin A, Patruno V, Poi ED, Marchesini F et al (2021) Chest high-resolution computed tomography in patients with connective tissue disease: pulmonary conditions beyond \u201cthe usual suspects.\u201d Curr Probl Diagn Radiol. https:\/\/doi.org\/10.1067\/j.cpradiol.2021.07.007","journal-title":"Curr Probl Diagn Radiol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06660-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06660-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06660-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T14:06:57Z","timestamp":1699884417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06660-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6660"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06660-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"18 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the local Ethics Committees of People\u2019s Hospital of Zhengzhou University with the reference number: HNEECKY-2020(31), and the written informed consents were obtained from the patients prior to submission of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}